3. Add 1 mL of eluting solution and note the time.

4. Stopper the tube and mix by inversion for 90 seconds.

5. Remove the stopper and promptly centrifuge the tube

at 900–1000 g for 45 seconds.

6. Transfer supernatant fluid to a clean test tube and add

5–6 drops of neutralizing solution; save red blood cells

for use in adsorption studies if needed.

7. Check pH; adjust it, if necessary, to pH 7.0 by adding

more neutralizing solution.

8. Centrifuge at 900–1000 g for 2–3 minutes to remove

precipitate that forms after neutralization. Harvest

the supernatant eluate and test it in parallel with

supernatant saline from final wash.

Notes

1. Once the red blood cells have been rendered DATnegative, they may be tested for the presence of blood

group antigens, except those of the Kell blood group

system. Expression of antigens in the Kell system is

markedly weakened after citric acid treatment.

2. Citric acid modified red blood cells may also be treated

with protease and used in autologous adsorption

studies.

Cold Acid Elution

Specimen

Packed DAT positive red blood cells washed six times with

saline.

Reagents

1. Glycine-HCl (0.1 M, pH 3.0), prepared by dissolving

3.75 g of glycine and 2.922 g of sodium chloride in

500 mL of distilled water. Adjust pH to 3.0 with 12N

HCl. Store at 4°C.

2. Phosphate buffer (0.8 M, pH 8.2), prepared by

dissolving 109.6 g of Na2HPO4 and 3.8 g of KH2PO4 in

approximately 600 mL of distilled water. Adjust pH, if

necessary, with either 1N NaOH or 1N HCl. Dilute to a

final volume of 1 titer with distilled water. Store at 4°C.

3. Normal saline, at 4°C.

4. Supernatant saline from final wash of red blood cells

to be tested.

Procedure

1. Place the red blood cells in 13 × 100 mm test tube and

chill them in an ice bath for 5 minutes before adding

glycine-HCl.

2. Add 1 mL of chilled saline and 2 mL of chilled glycineHCl to 1 mL of washed red blood cells.

3. Mix and incubate the tube in an ice bath for 1 minute.

4. Quickly centrifuge the tube at 900–1000 g for 2–3

minutes.

5. Transfer the supernatant eluate into a clean test tube,

and add 0.1 mL of pH 8.2 phosphate buffer for each

1 mL of eluate.

6. Mix and centrifuge at 900–1000 g for 2–3 minutes.

7. Transfer the supernatant eluate into a clean test tube,

and add test in parallel with the supernatant saline

from the final wash.

Notes

1. Keep glycine in ice bath during use, to maintain correct

pH.

2. Phosphate buffer will crystallize during storage at 4°C.

Redissolve it at 37°C before use.

3. Addition of phosphate buffer restores neutrality to

the acidic eluate. Unneutralized acidity may cause

hemolysis of the reagent red blood cells used in

testing the eluate. The addition of 22% bovine albumin

(one part to four parts of eluate) may reduce such

hemolysis.

Glycine-HCl/EDTA Elution

Specimen

Packed DAT positive red blood cells washed six times with

saline.

Reagents

1. Disodium EDTA (10% w/v): Na2EDTA2 H2O,10 g,

distilled water 100 mL.

2. Glycine-HCl (0.1 M at pH 1.5): Glycine 3.754 g; NaCl

2.922 g; distilled water 500 mL; adjust to pH 1.5 with

12 N HCl; store at 4°C.

3. TRIS base: Hydroxymethyl aminomethane, 12.1 g;

distilled water 100 mL.

4. Supernatant saline from final wash of the red blood

cells to be tested.

Procedure

1. Mix 4 mL of glycine-HCl and 1 mL of EDTA in 16 × 100

mm test tube.

2. Immediately add 1 mL of washed red blood cells and

mix well.

3. Incubate at room temperature for 1–2 minutes.

Blood Banking (Immunohematology) 351

4. Centrifuge the tube at 900–1000 g for 2–3 minutes.

5. Transfer the supernatant eluate into a clean test tube

and adjust to pH 7.5 with 1 M TRIS base.

6. Mix and centrifuge at 900–1000 g for 2–3 minutes.

7. Transfer the supernatant eluate into a clean test tube,

and test it in parallel with the supernatant saline from

the final wash.

Notes

1. Once the red blood cells have been rendered DATnegative, they may be tested for the presence of

blood group antigens, except those in the Kell system.

Treatment with glycine-HCl/EDTA denatures Kell

system antigens.

2. Red blood cells modified with glycine-HCl/EDTA

may be treated with protease and used in autologous

adsorption studies.

Heat Elution

Specimen

Packed DAT positive red blood cells washed six times with

saline.

Reagents

1. Six percent bovine albumin, prepared by diluting 22%

or 30% bovine albumin with saline.

2. Supernatant saline from final wash of the red blood

cells to be tested.

Procedure

1. Mix equal volumes of washed packed cells and 6%

bovine albumin in 13 × 100 mm test tube.

2. Place the tube at 56°C for 10 minutes. Agitate the tube

periodically during the incubation period.

3. Centrifuge the tube at 900–1000 g for 2–3 minutes,

preferably in a heated centrifuge.

4. Immediately transfer the supernatant eluate into a

clean test tube, and test in parallel with supernatant

saline from final wash.

Donath-Landsteiner Test

Specimen

Serum separated from freshly collected blood sample

maintained at 37°C.

Reagents

1. Freshly collected normal serum, to use as a source of

complement.

2. 50% suspension of washed group O red blood cells that

express the P antigen.

Procedure

1. Label three sets of three 10 × 75 mm test tubes as

follows: A1-A2-A3; B1-B2-B3; C1-C2-C3.

2. To tubes 1 and 2 of each set, add 10 volumes of the

patient’s serum.

3. To tubes 2 and 3 of each set, add 10 volumes of fresh

normal serum.

4. To all tubes, add one volume of 50% suspension of

washed P-positive red blood cells and mix well.

5. Place the three ‘A’ tubes in a bath of melting ice for 30

minutes, and then at 37°C for 1 hour.

6. Place the three ‘B’ tubes in a bath of melting ice, and

keep them in melting ice for 90 minutes.

7. Place the three ‘C’ tubes at 37°C, and keep them at 37°C

for 90 minutes.

8. Centrifuge all tubes, and examine the supernatant fluid

for hemolysis.

Interpretation

The Donath-Landsteiner test is considered positive when

the patient serum, with or without added complement,

causes hemolysis in the tubes that were incubated first in

melting ice and then at 37°C (i.e. tubes A1 and A2), and there

is no hemolysis in any of the tubes maintained throughout

at 37°C or in melting ice. The A3, B3 and C3 tubes serve as a

control for complement activity and should not manifest

hemolysis.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more